U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 078899
Company: ZYDUS PHARMS USA INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BROMOCRIPTINE MESYLATE BROMOCRIPTINE MESYLATE EQ 5MG BASE CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/30/2008 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/27/2022 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

01/19/2021 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

08/13/2012 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

BROMOCRIPTINE MESYLATE

CAPSULE;ORAL; EQ 5MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BROMOCRIPTINE MESYLATE BROMOCRIPTINE MESYLATE EQ 5MG BASE CAPSULE;ORAL Prescription No AB 077226 MYLAN
BROMOCRIPTINE MESYLATE BROMOCRIPTINE MESYLATE EQ 5MG BASE CAPSULE;ORAL Prescription No AB 078899 ZYDUS PHARMS USA INC
PARLODEL BROMOCRIPTINE MESYLATE EQ 5MG BASE CAPSULE;ORAL Prescription Yes AB 017962 SS PHARMA
Back to Top